Clin2
NCT07068607Likely a fitRecruiting

Comparing two treatments for H. pylori infection

Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer

Treatments studied

Part of Cancer, Digestive system clinical trials.

This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
400 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old
  • You have tested positive for H. pylori (a stomach infection) and have never been treated for it
  • You are not allergic to any of the study medications (vonoprazan, amoxicillin, tetracycline, metronidazole, or clarithromycin)
  • You have not taken antibiotics or acid-reducing medicines in the past month (except aspirin ≤100 mg/day)
  • You are not pregnant, breastfeeding, or planning pregnancy during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06168214Recruiting· Phase 4
Comparing treatments for H. pylori infection

This study compares several different 2-week treatment plans to see which works best for wiping out H. pylori, a bacteria that can cause stomach ulcers and other digestive problems. If you have H. pylori, you may be able to join and receive one of the treatments.

Xi'an, Shaanxi
NCT07293910Recruiting· Phase 2
Comparing treatments for H. pylori infection

This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.

Tanta
NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang
NCT07624422Not yet recruiting· Phase 4
Two antibiotic combinations for H. pylori stomach infection

This study compares two different antibiotic treatment plans for H. pylori, a common stomach bacteria that causes ulcers and digestive problems. The trial tests whether a higher dose of one medication (vonoprazan) works better than a different antibiotic combination.

Damascus
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana

Hear when a new Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.